BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 14677664)

  • 1. Amiodarone: guidelines for use and monitoring.
    Siddoway LA
    Am Fam Physician; 2003 Dec; 68(11):2189-96. PubMed ID: 14677664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone drug interactions: potential beneficial and adverse effects.
    Fontaine G
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I17-20. PubMed ID: 3271186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term drug interaction of warfarin with amiodarone].
    Hirmerová J; Suchý D; Mádr T
    Cas Lek Cesk; 2003 Jan; 142(1):39-42. PubMed ID: 12693297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone--still a useful antiarrhythmic drug].
    Gjesdal K
    Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1532-3. PubMed ID: 18587462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone therapy for atrial rhythm control: insights gained from a single center experience.
    Chandhok S; Schwartzman D
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):714-8. PubMed ID: 17504255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Did you know? Why amiodarone requires diligent monitoring?
    Morris D; Cameron N
    Can J Cardiovasc Nurs; 2011; 21(4):3-6. PubMed ID: 22165500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of amiodarone therapy: efficacy and side effects.
    Hilleman D; Miller MA; Parker R; Doering P; Pieper JA
    Pharmacotherapy; 1998; 18(6 Pt 2):138S-145S. PubMed ID: 9855346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone to prevent recurrence of atrial fibrillation.
    Furmaga EM; Good CB
    N Engl J Med; 2000 Aug; 343(8):579; author reply 579-80. PubMed ID: 10979785
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone and the thyroid.
    Basaria S; Cooper DS
    Am J Med; 2005 Jul; 118(7):706-14. PubMed ID: 15989900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
    Batcher EL; Tang XC; Singh BN; Singh SN; Reda DJ; Hershman JM;
    Am J Med; 2007 Oct; 120(10):880-5. PubMed ID: 17904459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term preventive effect and safety of amiodarone in patients with paroxysmal atrial fibrillation refractory to class I antiarrhythmic agents: analysis based on patient profiles].
    Komatsu T; Horiuchi D; Nakamura S; Suzuki O; Yomogida K; Okumura K
    J Cardiol; 2005 Jan; 45(1):11-7. PubMed ID: 15700925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
    Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.